Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL383P is a human genomic pseudogene, part of a large family derived from 7SL RNA, the essential non-coding RNA component of the signal recognition particle (SRP)[1][5][7]. 7SL RNA pseudogenes are diverse, often truncated, and result from the reverse transcription of 7SL RNA and reintegration into the genome. Unlike functional 7SL RNA, which is critical for directing proteins to membranes during translation, 7SL RNA pseudogenes (such as RN7SL383P) are typically not transcribed into functional RNA or protein and lack biological activity[1][5][7]. Their presence in the genome is thought to reflect historical gene duplications and retrotransposition events, but they do not contribute to cellular function or disease and are not drug targets[1][7]. The parent molecule, 7SL RNA, is involved in co-translational protein translocation as part of SRP, but RN7SL383P does not participate in this pathway[6]. There is no misspelling, though it represents a molecule type (pseudogene) that is not a canonical drug target, receptor, enzyme, or transporter. Most research databases and gene resources define RN7SL383P as a "pseudogene" with no known or predicted function[1]. Summary: RN7SL383P is correctly named as a pseudogene, not a receptor, enzyme, or drug target. It is biologically inert, has no disease association, no therapeutically relevant interactions, and should not be considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 383, pseudogene (RN7SL383P).